Andrew J Innes

19PUBLICATIONS
45CO-AUTHORS
Molecular targetsHaematological tumoursCardiology (incl. cardiovascular diseases)HaematologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Apr 15, 2026
Spliceosome induction is a druggable dependency of RAS-driven senescence and cancer.

|Sep 19, 2024
Impact of BCR::ABL1 single nucleotide variants on asciminib efficacy.

Andrew J Innes, Chloe Hayden, Victoria Orovboni

|Mar 04, 2024
Treatment-free remission in CML patients with additional chromosome abnormalities in the Philadelphia-positive clone or variant Philadelphia translocations.

Simone Claudiani, Lynette Chee, Fiona Fernando

|Feb 29, 2024
Long-term outcomes after upfront second-generation tyrosine kinase inhibitors for chronic myeloid leukemia: managing intolerance and resistance.

Simone Claudiani, Farhan Chughtai, Afzal Khan

|Jan 31, 2024
Promoter-centred chromatin interactions associated with EVI1 expression in EVI1+3q- myeloid leukaemia cells.

Han Leng Ng, Mark E Robinson, Philippa C May

|Dec 01, 2023
The management of myelofibrosis: A British Society for Haematology Guideline.

Donal P McLornan, Bethan Psaila, Joanne Ewing

Pageof 4

Frequent Collaborators

4 joint publications

Adam Mead

4 joint publications

Simone Claudiani

3 joint publications

Bethan Psaila

3 joint publications

Mary Frances McMullin